Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CODXTSE:DRXNYSE:GRP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$0.27-1.7%$0.32$0.23▼$2.23$9.10M0.57237,608 shs202,381 shsDRXADF GroupC$8.39+4.9%C$6.82C$5.00▼C$17.45C$250.76M0.5793,872 shs74,155 shsGRPGranite Reit$0.00$39.05▼$39.55N/AN/A81,854 shs20 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics-1.74%-9.09%-9.67%-38.55%-82.96%DRXADF Group+4.88%+23.56%+9.82%+7.70%-50.36%GRPGranite Reit0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCODXCo-Diagnostics4.1531 of 5 stars3.53.00.04.42.50.01.3DRXADF GroupN/AN/AN/AN/AN/AN/AN/AN/AGRPGranite ReitN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCODXCo-Diagnostics 3.00Buy$5.501,929.52% UpsideDRXADF Group 0.00N/AN/AN/AGRPGranite Reit 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CODX, UKW, DRX, and GRP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/28/2025CODXCo-DiagnosticsD Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/28/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$10.003/28/2025CODXCo-DiagnosticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$1.50 ➝ $1.00(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCODXCo-Diagnostics$3.71M2.45N/AN/A$2.81 per share0.10DRXADF GroupC$350.79M0.71C$1.89 per share4.43C$5.45 per share1.54GRPGranite ReitN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCODXCo-Diagnostics-$35.33M-$1.17N/AN/AN/A-563.93%-54.94%-49.28%8/6/2025 (Estimated)DRXADF GroupC$58.23MC$1.924.38∞N/A16.60%35.82%16.20%N/AGRPGranite ReitN/AN/A0.00N/AN/AN/AN/AN/AN/ALatest CODX, UKW, DRX, and GRP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025CODXCo-Diagnostics-$0.33-$0.24+$0.09-$0.24$0.38 million$0.05 million3/27/2025Q4 2024CODXCo-Diagnostics-$0.34-$0.36-$0.02-$0.36$0.38 million$0.15 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCODXCo-DiagnosticsN/AN/AN/AN/AN/ADRXADF GroupC$0.040.48%N/A2.09%N/AGRPGranite ReitN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCODXCo-DiagnosticsN/A6.926.70DRXADF Group28.512.221.74GRPGranite ReitN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCODXCo-Diagnostics14.99%DRXADF Group4.14%GRPGranite ReitN/AInsider OwnershipCompanyInsider OwnershipCODXCo-Diagnostics8.40%DRXADF Group12.36%GRPGranite ReitN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCODXCo-Diagnostics10033.57 million29.98 millionOptionableDRXADF Group55029.89 millionN/ANot OptionableGRPGranite ReitN/AN/AN/ANot OptionableCODX, UKW, DRX, and GRP HeadlinesRecent News About These CompaniesGranite REIT Announces Renewal of Normal Course Issuer BidMay 22, 2025 | finance.yahoo.comRBC’s REIT analyst provides top picks ahead of earnings seasonApril 24, 2025 | theglobeandmail.comGranite REIT issues C$300M in unsecured debenturesFebruary 4, 2025 | msn.comGranite REIT: Dividend Hike And Improving FundamentalsDecember 19, 2024 | seekingalpha.comGranite Real Estate Investment Trust (4I70.F)November 21, 2024 | nz.finance.yahoo.comCIBC analyst picks most promising REITs following earnings seasonNovember 19, 2024 | theglobeandmail.comGranite REIT Declares Distribution for October 2024October 17, 2024 | finance.yahoo.comGranite REIT Announces C$800 Million Offering of Senior Unsecured DebenturesOctober 2, 2024 | finance.yahoo.comGranite Quarry holding public hearing on incentives for 170-job company expansionSeptember 25, 2024 | salisburypost.com‘The outlook for next quarter could spell trouble’, says Barclays strategistSeptember 9, 2024 | theglobeandmail.comSeeing stability for Canadian REITs, a CIBC analyst previews earnings season and reveals top picksAugust 21, 2024 | theglobeandmail.comGoogle acknowledges it "missed the mark" with Team Pixel program language for Pixel 9 reviewsAugust 16, 2024 | msn.comBenchmarks tease upcoming Intel Granite Rapids 120-core, 240-thread monster CPUAugust 16, 2024 | techspot.comWhy investors should buy into logistics, skip utilitiesAugust 16, 2024 | ca.finance.yahoo.comKite Realty Group Announces Pricing of $350 Million Senior Notes OfferingAugust 14, 2024 | bakersfield.comGRP-U Stock Earnings: Granite Real Estate Inc. Stapled Units, each consisting of one unit of Granite Real Estate Trust and one common share of Granite REIT Inc. Reported ...August 8, 2024 | msn.comGranite Announces 2024 Second Quarter Results and the Issuance of its 2023 Global ESG+R ReportAugust 7, 2024 | finance.yahoo.com(GRP.U) Long Term Investment AnalysisJuly 26, 2024 | news.stocktradersdaily.comTop REIT picks, profit report preview from RBC analystJuly 24, 2024 | theglobeandmail.comHome REIT tenant surrenders hundreds of properties after regulatory probeMay 29, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCODX, UKW, DRX, and GRP Company DescriptionsCo-Diagnostics NASDAQ:CODX$0.27 0.00 (-1.74%) Closing price 06/16/2025 04:00 PM EasternExtended Trading$0.29 +0.02 (+5.54%) As of 06/16/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.ADF Group TSE:DRXC$8.39 +0.39 (+4.88%) As of 06/16/2025 04:00 PM EasternADF Group Inc involves in the design and engineering of connections, fabrication, including industrial coating, and the installation of steel structures and steel built-ups, as well as miscellaneous and architectural metalwork. The company's products and services intended for the five principal segments of the non-residential construction industry: Office towers and high-rises, Commercial and recreational buildings, Airport facilities, Industrial complexes, and Transport infrastructures. It serves the client base in the non-residential construction industry, such as general contractors, project owners, engineering firms and project architects, and other steel structure fabricators. The company operates in the United States and Canada.Granite Reit NYSE:GRPGranite Real Estate Investment Trust engages in the development, management, rental, and ownership of industrial, warehouse, and logistic properties. It operates through the following geographical segments: Canada, United States, Austria, Germany, Netherlands, and Other Europe. The company is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
